Blue Door Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,845
Closed -$1.41M 22
2022
Q1
$1.41M Hold
10,845
0.82% 19
2021
Q4
$1.66M Buy
+10,845
New +$1.68M 1.52% 18

Other funds holding IBB

Blue Door Asset Management's IBB Position: Q2 2022 in Review

Blue Door Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 10,845 shares — an estimated $1.41M sold.

Blue Door Asset Management first reported a position in IBB in Q4 2021 and held it in 2 quarters. The position peaked at $1.66M in Q4 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

  • Blue Door Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
  • Blue Door Asset Management sold 10,845 iShares Biotechnology ETF shares in Q2 2022, an estimated $1.41M.
  • Blue Door Asset Management first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 2 quarters.
  • Blue Door Asset Management's iShares Biotechnology ETF position peaked at $1.66M in Q4 2021.
  • 858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Blue Door Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.